 |
 |
 |
Bio Medica Laboratories IPO Details, Price, Market Lot
Bio Medica Laboratories IPO Details |
|
| IPO Open Date | |
| IPO Close Date | |
| IPO Issue Size | |
| Issue (Sale Type) | |
| Fresh Issue | |
| Offer for Sale | |
| Offered to Public | |
| Reserved for Market Maker | |
| Market Maker | |
| Share Holding (Pre Issue) | |
| Share Holding (Post Issue) | |
| Listing At | |
Bio Medica Laboratories IPO Price |
|
| has set a price band of , lot size is of and face value is . | |
| Face Value | |
| Price Band | ₹132 to ₹139 per share |
| Lot Size | 1,000 shares |
| IPO Issue Type | |
Bio Medica Laboratories IPO Time Table |
|
| IPO will open for subscription on and close on . Basis of Allotment will be decided on , initiation of refund will begin on and IPO will be listed on at . | |
| IPO Open Date | |
| IPO Close Date | |
| Basis of Allotment Date | |
| Initiation of Refunds | |
| Credit of Share to Demat Account | |
| IPO Listing Date | |
| IPO Cut-off time (UPI mandate confirmation) | |
Bio Medica Laboratories IPO Reservation |
|
| Total shares offered by IPO is . Out of which is reserved for retail, is reserved for HNI (NII), is reserved for QIB, and is reserved for market maker . | |
| Retail Quota | |
| NII Quota | |
| QIB Quota | |
| Market Maker Quota | |
| Total | |
Company Promotor & Promotor's Holding |
|
| Pre Issue Promotor Holding | |
| Post Issue Promotor Holding | |
Bio Medica Laboratories IPO Registrar |
|
Bio Medica Laboratories IPO Lead Manager |
|
| is the book running lead manager, is the registrar and the market maker of the IPO | |
IPO Financial Indicator (valuations) |
|
| Market Capitalization | |
| Debt/Equity | |
| ROE | |
| ROCE | |
| RONW | |
| P/BV | |
| PAT Margin | |
| EBITDA | |
Bio Medica Laboratories IPO P/E ratio and EPS |
|
| EPS (Pre IPO) | |
| EPS (Post IPO) | |
| P/E ratio (Pre IPO) | |
| P/E ratio (Post IPO) | |
Bio Medica Laboratories IPO Lot Size and Required Amount
has set a price band of and lot size is of . Retail investors can bid for a minimum and maximum of lots ( shares), requiring an investment of . Small HNI (sHNI) investors can bid for a minimum of lots ( shares), requiring an investment of and maximum of lots ( shares), requiring an investment of . Big HNI (bids > 10 Lakh, bHNI) investors can bid for a minimum of Lots ( shares), requiring an investment of . Calculated at the cut-off price (the upper end of the price band).
| Number of Shares Per Lot = | |||
| Application | Lot(s) | Shares | Amount |
| Retail (Minimum) | |||
| Retail (Maximum) | |||
| S-HNI (Minimum) | |||
| S-HNI (Maximum) | |||
| B-HNI (Minimum) | |||
| Number of Shares Per Lot = | |||
| Application | Lot(s) | Shares | Amount |
| Retail (Min) | |||
| Retail (Max) | |||
| S-HNI (Min) | |||
| S-HNI (Max) | |||
| B-HNI (Min) | |||
| 30 Nov 25 In Cr. | 31 Mar 25 In Cr. | 31 Mar 24 In Cr. | 31 Mar 23 In Cr. | |
|---|---|---|---|---|
| Assets | 65.17 | 39.12 | 19.53 | 17.57 |
| Revenue | 28.63 | 38.33 | 15.34 | 16.25 |
| Profit After Tax | 8.66 | 9.79 | 2.5 | 0.33 |
| EBITDA | 13.45 | 15.21 | 5.63 | 1.7 |
| Net Worth | 17.12 | 14.73 | 4.94 | 2.44 |
| Total Borrowing | 38.17 | 15.01 | 10.49 | 9.61 |
| Reserves & Surplus | 7.94 | 5.55 | 4.84 | 2.34 |
| Contact & Address | |
| Address: Phone: Email: Website: |
|
| IPO Prospectus | |
Bio Medica Laboratories IPO Object of Issue
S.No | Objects | Amount (in ₹, Cr) |
|---|---|---|
1 | Repayment of loan | 6.50 |
2 | Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises | 28.50 |
3 | General Corporate Purposes | |
Total: | 35.00 |
Bio Medica Laboratories IPO FAQs
Bio Medica Laboratories IPO is an SME IPO. The company will raise upto 52 crore 43 lakh 8 thousand rupees for 37,72,000 shares. Face value is ₹10 per share, Price band is ₹132 to ₹139 per share, and cutt off price is ₹139 per share. The IPO opens on 21 May 2026 and closes on 25 May 2026. Skyline Financial Service Pvt Ltd is the registrar and shares of Bio Medica Laboratories IPO will be listed at NSE SME.
The issue size of IPO is 37,72,000 shares (aggregating up to 52 crore 43 lakh 8 thousand rupees). For fresh issue: 33,95,000 shares (aggregating up to 47 crore 19 lakh 5 thousand rupees) and for offer for sale: 3,77,000 shares (aggregating up to 5 crore 24 lakh 3 thousand rupees).
Price band for IPO is ₹132 to ₹139 per share.
The lot size of Bio Medica Laboratories IPO is of 1000. Minimum order quantity for retail investor is 2,000 shares (2 lots) and required amount is ₹2,78,000. Minimum order quantity for sHNI is 3,000 shares ( lots) and required amount is ₹4,17,000. Minimum order quantity for bHNI investor is 8,000 shares ( lots) and required amount is ₹11,12,000.
The investors portion reserved for QIB is 36,000 shares (0.95%), reserved for HNI is 17,55,000 shares (46.53%) and 17,92,000 shares (47.51%) reserved for retail investors.
The IPO will be available for subscription from 21 May 2026 to 25 May 2026. IPO open date is 21 May 2026 and close date is 25 May 2026.
Allotment date for IPO is 26 May 2026. On the allotment date, after the IPO allotment status is announced, investors can check their IPO application allotment status on their respective IPO registrar.
The registrar for IPO is Skyline Financial Service Pvt Ltd.
The IPO will be listed on 29 May 2026 at NSE SME.